Hubro Therapeutics to present at ABG Oncology Seminar 23 November

Hubro Therapeutics CEO Jon Amund Eriksen will at this invite-only present the company and the latest development to scandinavian specialist investors and institutions. The presentation will be held in English and last for 20 min. iIncluding 5 min. Q&A.

For attendance, please contact your local ABGSC representative or Corporate Access.

T: +47 22 01 00 00


This website uses cookies to ensure you get the best experience on our website.